Olopatadine intranasal/mometasone, intranasal

Name: Olopatadine intranasal/mometasone, intranasal

Dosing & Uses

Allergic Rhinitis

New intranasal fixed-dose combination product pending FDA approval for allergic rhinitis

Pharmacology

Mechanism of Action

Olopatadine: Antihistamine (H1 antagonist); inhibits release of histamine from mast cells

Mometasone: Corticosteroid with potent anti-inflammatory properties; elicits effects on various cells, including mast cells and eosinophils; also elicits effects on inflammatory mediators (eg, histamine, eicosanoids, leukotrienes, cytokines)

Patient Handout

Print without Office InfoPrint with Office Info
(web3)